Presentation TCT 2016 TCT 1570: Transcatheter Closure of a Sinus Venosus Atrial Septal Defect in a Poor Surgical Candidate Presenter: Ruediger S. Lange, John F. Rhodes, Akanksha Thakkar November 01, 2016
Presentation TCT 2016 Prospective Single Center FIH Clinical Trial to Evaluate the Safety and Effectiveness of a Septal Occluder with Bioresorbable Framework in Patients with Clinically Significant ASD or PFO Presenter: Ted Feldman, David Hildick-Smith, Kolja Sievert November 01, 2016
Presentation TCT 2016 TCT 1520: Percutaneous Closure of Aortic Pseudo Aneurysm in a Young Female With Atrial Septal Occluder Presenter: David R. Holmes Jr., Clifford J. Kavinsky, shantanu Deshpande October 31, 2016
Presentation TCT 2016 Future Therapy for Symptomatic HCM Patients With and Without Dynamic Obstruction Presenter: George S. Hanzel, Antoine Lafont, Michael A. Fifer October 30, 2016
Presentation TCT 2016 Debate: Surgery, Septal Ablation or New Medical Therapy for Obstructive HCM - Septal Ablation Is As Good As Surgery and Less Invasive! Presenter: George S. Hanzel, Antoine Lafont, Carey D. Kimmelstiel October 30, 2016
Presentation TCT 2016 TCT 1559: TMVR Using a Fully Repositionable (LOTUS) Valve in a Patient With Severe MAC, Septal Hypertrophy, Left Main Disease, and Severe Aortic Stenosis: Importance of Preprocedural Planning Presenter: Henrique B. Ribeiro, Dimytri Alexandre Siqueira, Chris Meduri October 30, 2016
Presentation TCT 2016 Debate: Surgery, Septal Ablation or New Medical Therapy for Obstructive HCM - Surgery Is Always the First Option! Presenter: George S. Hanzel, Antoine Lafont, Daniel G Swistel October 30, 2016
Presentation TCT 2016 Debate: Surgery, Septal Ablation or Medical Therapy for Obstructive HCM Not so Fast: Try Optimizing Medical Therapy First! Presenter: George S. Hanzel, Antoine Lafont, Michael A. Fifer October 30, 2016
Presentation TCT 2016 Novel Approaches for Septal Ablation: Beyond Alcohol Presenter: Srihari S. Naidu, Paul Sorajja October 30, 2016
Presentation TCT 2016 Alcohol Septal Ablation of Ventricular Tachycardia Presenter: Srihari S. Naidu, Paul Sorajja, George D. Dangas October 30, 2016
Presentation TCT 2016 An Alcohol Septal Ablation Case I Regret Presenter: Srihari S. Naidu, Paul Sorajja October 30, 2016
Presentation TCT 2016 My Best Alcohol Septal Ablation Case Presenter: Srihari S. Naidu, Paul Sorajja, George S. Hanzel October 30, 2016
Presentation TCT 2016 Good and Not So Good Cases to Consider for Alcohol Septal Ablation Presenter: Srihari S. Naidu, Paul Sorajja, John S. Douglas Jr October 30, 2016
Presentation TCT 2016 Debate: ICD or Pacemaker for High Grade AV Block After Alcohol Septal Ablation: Pro Pacing Presenter: Bernard J. Gersh, Harry Rakowski, Michael A. Fifer October 30, 2016
Presentation TCT 2016 Debate: ICD or Pacemaker for High Grade AV Block After Alcohol Septal Ablation: Pro ICD! Presenter: Bernard J. Gersh, Harry Rakowski, George S. Hanzel October 30, 2016
Presentation TCT 2016 When Is Pacing Needed in HCM Outside Invasive Management Settings Presenter: Bernard J. Gersh, Harry Rakowski October 30, 2016
Presentation TCT 2016 Medical Management of Non-Obstructive HCM: When and Which Medications? Presenter: Bernard J. Gersh, Harry Rakowski, John S. Douglas Jr October 30, 2016
Presentation TCT 2016 Genetic Testing in Hypertrophic Cardiomyopathy: Role in Prognostication and Screening Presenter: Howard C. Herrmann, Sherif F. Nagueh, Robert Roberts October 30, 2016
Presentation TCT 2016 Cardiac Catheterization Is Essential for Hemodynamic Assessment Presenter: Howard C. Herrmann, Sherif F. Nagueh October 30, 2016
Presentation TCT 2016 Prospective Single Center First-in-Human (FIH) Clinical Trial to Evaluate the Safety and Effectiveness of a Septal Occluder With Bioresorbable Framework in Patients With Clinically Significant Atrial Septum Defect (ASD) or Patent Foramen Ovale (PFO) Presenter: Horst Sievert October 30, 2016